2 completed, 1 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Unknown 1 |
Follow Embolic Stroke: new trials by email Literature Review of Embolic Stroke trials Research Report on Embolic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lixiana Acute Stroke Evaluation Registry Edoxaban 60 MG, Edoxaban 30 mg - Ischemic Stroke, Atrial Fibrillation | Phase 4 | Completed | University of Alberta | 70 | 2018-06-01 | 2024-04-05 |
| Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism Shuxuetong Injection, Placebo Injection - Embolic Stroke | Phase 4 | Completed | Beijing Tiantan Hospital | 2416 | 2017-05-12 | 2020-07-22 |
| Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling Aspirin and clopidogrel - Embolic Stroke | Phase 4 | Unknown | Beijing Tiantan Hospital | 1856 | 2015-01-01 | 2014-08-25 |
Atrial Fibrillation (1) · Cerebral Hemorrhage (1) · Ischemic Stroke (1) · Recurrence (1) · Stroke (1)
Brain Diseases (3) · Cardiovascular Diseases (3) · Central Nervous System Diseases (3) · Cerebrovascular Disorders (3) · Nervous System Diseases (3) · Vascular Diseases (3) · Ischemic Stroke (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Stroke (2) · Arrhythmias, Cardiac (1) · Disease Attributes (1) · Heart Diseases (1) · Hemorrhage (1) · Intracranial Hemorrhages (1)
Aspirin (1) · Clopidogrel (1) · edoxaban (1) · shuxuetong (1)
Beijing Tiantan Hospital (2) · University of Alberta (1)
China (2) · Canada (1)
Brian Buck, MD (1) · Ken Butcher, MD (1) · Youxiang Li, Professor (1)